Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia
| Tracking Information | |
|---|---|
| First Received Date ICMJE | March 11, 2010 |
| Last Updated Date | March 11, 2010 |
| Start Date ICMJE | April 2010 |
| Estimated Primary Completion Date | April 2010 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE | Not Provided |
| Original Primary Outcome Measures ICMJE | Not Provided |
| Change History | No Changes Posted |
| Current Secondary Outcome Measures ICMJE | Not Provided |
| Original Secondary Outcome Measures ICMJE | Not Provided |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia |
| Official Title ICMJE | Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi Arabia |
| Brief Summary | The purpose of this cross-sectional survey study is to describe the prevalence of asthma and Rhinitis symptoms among secondary school students in Saudi Arabia. |
| Detailed Description | Cross sectional survey based on ISAAC protocol to characterize the symptoms of asthma and rhinitis and measure their frequency and its prevalence among secondary schools students (age 15 to 18 years, boys and girls) in Riyadh city, Saudi Arabia in period from 1st of April 2010 to 31st of May 2010. The ISAAC protocol stated that the study population should consist of at least 3,000 students aged 15-18 years- in this case, enrolled in at least 40 randomly selected schools. The 15-18 year age group was chosen because it is the age most adolescents go to school regularly, making data collection easier. Once requested by the research team, the education authority will provide a list of all secondary schools in Riyadh city and the number of students by school and their grades. There are 400 secondary schools for boys and 400 school for girls (total number of boys and girls students 50,000). A two stage stratified random sample of 4000 students will be selected out of secondary schools for boys and girls , Their ages range from 16 to 18 years. |
| Study Type ICMJE | Observational |
| Study Design ICMJE | Observational Model: Case-Only Time Perspective: Cross-Sectional |
| Target Follow-Up Duration | Not Provided |
| Biospecimen | Not Provided |
| Sampling Method | Probability Sample |
| Study Population | 4000 students will be selected out of secondary schools for boys and girls , Their ages range from 16 to 18 years. |
| Condition ICMJE |
|
| Intervention ICMJE | Not Provided |
| Study Group/Cohort (s) | Not Provided |
| Publications * | Not Provided |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Enrolling by invitation |
| Estimated Enrollment ICMJE | 4000 |
| Estimated Completion Date | May 2010 |
| Estimated Primary Completion Date | April 2010 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Both |
| Ages | 15 Years to 18 Years |
| Accepts Healthy Volunteers | Yes |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | Not Provided |
| Administrative Information | |
| NCT Number ICMJE | NCT01085916 |
| Other Study ID Numbers ICMJE | KingAbdulazizMC 001 |
| Has Data Monitoring Committee | Yes |
| Responsible Party | Dr Mohamed Ouda Al Anaezi, King Abdul Aziz Medical City, Riyadh, Saudi Arabia. |
| Study Sponsor ICMJE | King Abdulaziz Medical City |
| Collaborators ICMJE | Merck |
| Investigators ICMJE | Not Provided |
| Information Provided By | King Abdulaziz Medical City |
| Verification Date | February 2010 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|